Cuban medical researchers have achieved a significant milestone in healthcare innovation with the presentation of preliminary results from Cardent, an artificial intelligence project designed to transform cardiovascular disease prediction and treatment. The breakthrough was showcased during a high-level meeting between President Miguel Díaz-Canel Bermúdez and leading health experts this week.
Cardiovascular diseases have maintained their position as Cuba’s primary mortality cause for over two decades, representing both the leading cause of death and the second highest contributor to potential years of life lost after cancer. Particularly affecting adults aged 30-69, these conditions drive premature mortality rates across the nation.
The Cardent initiative emerges from a two-year collaborative effort between Hermanos Ameijeiras Hospital, University of Havana, Havana Science and Technology Park, BioCubaFarma’s Combiomed division, and several other institutions. This project forms part of a broader trio of AI-driven medical research programs addressing movement disorders (including Parkinson’s disease), neurodegenerative conditions, and advanced multimodal X-ray imaging.
Dr. Ernesto Estévez Rams, Physics Professor at the University of Havana and distinguished Cuban Academy of Sciences member, emphasized that these projects represent scientific innovation initiatives developing cutting-edge technologies through data analysis and artificial intelligence. The research aims to enhance medical services and clinical technologies to international standards.
Eminent cardiologist Juan Prohías Martínez, PhD, head of the National Cardiology Group, highlighted AI’s transformative potential despite its relatively recent emergence in medical applications. The technology promises revolutionary advances in early disease detection, event prediction, and generation of personalized treatment algorithms.
President Díaz-Canel and health experts unanimously agreed that AI technologies serve to augment rather than replace medical specialists, though physicians must now develop proficiency in artificial intelligence applications. Dr. Estévez Rams detailed AI’s growing impact on disease classification, monitoring, and modeling within cardiovascular medicine.
Cuba’s unique advantages for medical AI development include its robust healthcare system, international prestige, participation in global health networks, extensive medical collaboration programs, comprehensive health data collection capabilities, and world-class medical specialists across multiple disciplines.
The implementation of AI is expected to significantly elevate preventive healthcare standards, stimulate development of new medical devices, and create innovative services that enhance population quality of life. Researchers stressed the parallel need for comprehensive training strategies encompassing physician education, technologist development, curriculum integration, and practical application in daily medical practice.
In related health updates, officials reported successful management of arboviruses with declining cases of both dengue and chikungunya nationwide. Mathematical modeling indicates progressive control of the epidemic wave, though authorities emphasize continued vector control measures to prevent summer resurgence.